Ebola virus (EBOV) is the causative agent of severe hemorrhagic fever in primates, with
human case fatality rates up to 90%. Today, there is neither a licensed vaccine nor a …

Ebola virus (EBOV) causes acute hemorrhagic fever in humans and non-human primates
with mortality rates up to 90%. So far there are no effective treatments available. This study …

Ebola virus causes lethal hemorrhagic fever in humans and nonhuman primates, but no
effective antiviral compounds are available for the treatment of this infection. The surface …

Ebola virus causes severe hemorrhagic fever in susceptible hosts. Currently, no licensed
vaccines or treatments are available; however, several experimental vaccines have been …

Ebola virus (EBOV) causes severe viral hemorrhagic fever in humans and non-human
primates, with a case fatality rate of up to 88% in human outbreaks. Over the past 3 years …

Out of an estimated 31,100 cases since their discovery in 1976, ebolaviruses have caused
approximately 13,000 deaths. The vast majority (∼ 11,000) of these occurred during the …

Ebola virus (EBOV) is considered one of the most aggressive infectious agents and is
capable of causing death in humans and nonhuman primates (NHPs) within days of …

Zaire ebolavirus is the causative agent of the current outbreak of hemorrhagic fever disease
in West Africa. Previously, we showed that a whole Ebola virus (EBOV) vaccine based on a …

Ebola virus (EBOV) is one of the most lethal filoviruses, with mortality rates of up to 90% in
humans. Previously, we demonstrated 100% and 50% survival of EBOV-infected …

Background For most classes of drugs, rapid development of therapeutics to treat emerging
infections is challenged by the timelines needed to identify compounds with the desired …